NCT00567034View on ClinicalTrials.gov

Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2011

Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG

naltrexone

50mg naltrexone, 1 tablet a day for 12 weeks.

DRUG

placebo

lactose placebo, 1 capsule every day for 12 weeks

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
lead

Mclean Hospital

OTHER

NCT00567034 - Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects | Biotech Hunter | Biotech Hunter